Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

SLC1A3 contributes to L-asparaginase resistance in solid tumors.

Sun J, Nagel R, Zaal EA, Ugalde AP, Han R, Proost N, Song JY, Pataskar A, Burylo A, Fu H, Poelarends GJ, van de Ven M, van Tellingen O, Berkers CR, Agami R.

EMBO J. 2019 Sep 16:e102147. doi: 10.15252/embj.2019102147. [Epub ahead of print]

2.

Impact of maternal childhood trauma on child behavioral problems: The role of child frontal alpha asymmetry.

van de Ven MCJ, van den Heuvel MI, Bhogal A, Lewis T, Thomason ME.

Dev Psychobiol. 2019 Aug 1. doi: 10.1002/dev.21900. [Epub ahead of print]

PMID:
31372993
3.

Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands.

van de Ven M, Retèl VP, Koffijberg H, van Harten WH, IJzerman MJ.

Lung Cancer. 2019 Aug;134:34-41. doi: 10.1016/j.lungcan.2019.05.023. Epub 2019 May 21.

4.

Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.

Gogola E, Duarte AA, de Ruiter JR, Wiegant WW, Schmid JA, de Bruijn R, James DI, Llobet SG, Vis DJ, Annunziato S, van den Broek B, Barazas M, Kersbergen A, van de Ven M, Tarsounas M, Ogilvie DJ, van Vugt M, Wessels LFA, Bartkova J, Gromova I, Andújar-Sánchez M, Bartek J, Lopes M, van Attikum H, Borst P, Jonkers J, Rottenberg S.

Cancer Cell. 2019 Jun 10;35(6):950-952. doi: 10.1016/j.ccell.2019.05.012. No abstract available.

5.

Micro cone beam computed tomography for sensitive assessment of radiation-induced late lung toxicity in preclinical models.

van Berlo D, Khmelinskii A, Gasparini A, Salguero FJ, Floot B, de Wit N, van de Ven M, Song JY, Coppes RP, Verheij M, Sonke JJ, Vens C.

Radiother Oncol. 2019 Sep;138:17-24. doi: 10.1016/j.radonc.2019.05.007. Epub 2019 May 27.

PMID:
31146069
6.

EZH2 Is Overexpressed in BRCA1-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based Chemotherapy.

Puppe J, Opdam M, Schouten PC, Jóźwiak K, Lips E, Severson T, van de Ven M, Brambillasca C, Bouwman P, van Tellingen O, Bernards R, Wesseling J, Eichler C, Thangarajah F, Malter W, Pandey GK, Ozretić L, Caldas C, van Lohuizen M, Hauptmann M, Rhiem K, Hahnen E, Reinhardt HC, Büttner R, Mallmann P, Schömig-Markiefka B, Schmutzler R, Linn S, Jonkers J.

Clin Cancer Res. 2019 Jul 15;25(14):4351-4362. doi: 10.1158/1078-0432.CCR-18-4024. Epub 2019 Apr 29.

PMID:
31036541
7.

An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity.

Kopper O, de Witte CJ, Lõhmussaar K, Valle-Inclan JE, Hami N, Kester L, Balgobind AV, Korving J, Proost N, Begthel H, van Wijk LM, Revilla SA, Theeuwsen R, van de Ven M, van Roosmalen MJ, Ponsioen B, Ho VWH, Neel BG, Bosse T, Gaarenstroom KN, Vrieling H, Vreeswijk MPG, van Diest PJ, Witteveen PO, Jonges T, Bos JL, van Oudenaarden A, Zweemer RP, Snippert HJG, Kloosterman WP, Clevers H.

Nat Med. 2019 May;25(5):838-849. doi: 10.1038/s41591-019-0422-6. Epub 2019 Apr 22.

PMID:
31011202
8.

Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin.

Nagel R, Avelar AT, Aben N, Proost N, van de Ven M, van der Vliet J, Cozijnsen M, de Vries H, Wessels LFA, Berns A.

Mol Cancer Ther. 2019 Apr;18(4):762-770. doi: 10.1158/1535-7163.MCT-18-0972. Epub 2019 Mar 14.

9.

Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer.

Annunziato S, de Ruiter JR, Henneman L, Brambillasca CS, Lutz C, Vaillant F, Ferrante F, Drenth AP, van der Burg E, Siteur B, van Gerwen B, de Bruijn R, van Miltenburg MH, Huijbers IJ, van de Ven M, Visvader JE, Lindeman GJ, Wessels LFA, Jonkers J.

Nat Commun. 2019 Jan 23;10(1):397. doi: 10.1038/s41467-019-08301-2.

10.

Long-term expanding human airway organoids for disease modeling.

Sachs N, Papaspyropoulos A, Zomer-van Ommen DD, Heo I, Böttinger L, Klay D, Weeber F, Huelsz-Prince G, Iakobachvili N, Amatngalim GD, de Ligt J, van Hoeck A, Proost N, Viveen MC, Lyubimova A, Teeven L, Derakhshan S, Korving J, Begthel H, Dekkers JF, Kumawat K, Ramos E, van Oosterhout MF, Offerhaus GJ, Wiener DJ, Olimpio EP, Dijkstra KK, Smit EF, van der Linden M, Jaksani S, van de Ven M, Jonkers J, Rios AC, Voest EE, van Moorsel CH, van der Ent CK, Cuppen E, van Oudenaarden A, Coenjaerts FE, Meyaard L, Bont LJ, Peters PJ, Tans SJ, van Zon JS, Boj SF, Vries RG, Beekman JM, Clevers H.

EMBO J. 2019 Feb 15;38(4). pii: e100300. doi: 10.15252/embj.2018100300. Epub 2019 Jan 14.

11.

Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient Tumors.

Barazas M, Gasparini A, Huang Y, Küçükosmanoğlu A, Annunziato S, Bouwman P, Sol W, Kersbergen A, Proost N, de Korte-Grimmerink R, van de Ven M, Jonkers J, Borst GR, Rottenberg S.

Cancer Res. 2019 Feb 1;79(3):452-460. doi: 10.1158/0008-5472.CAN-18-2077. Epub 2018 Dec 10.

12.

Consolidation and prediction of long-term treatment effect of group and online mindfulness-based cognitive therapy for distressed cancer patients.

Cillessen L, Schellekens MPJ, Van de Ven MOM, Donders ART, Compen FR, Bisseling EM, Van der Lee ML, Speckens AEM.

Acta Oncol. 2018 Oct;57(10):1293-1302. doi: 10.1080/0284186X.2018.1479071. Epub 2018 Jun 22.

PMID:
29932784
13.

Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.

Gogola E, Duarte AA, de Ruiter JR, Wiegant WW, Schmid JA, de Bruijn R, James DI, Guerrero Llobet S, Vis DJ, Annunziato S, van den Broek B, Barazas M, Kersbergen A, van de Ven M, Tarsounas M, Ogilvie DJ, van Vugt M, Wessels LFA, Bartkova J, Gromova I, Andújar-Sánchez M, Bartek J, Lopes M, van Attikum H, Borst P, Jonkers J, Rottenberg S.

Cancer Cell. 2018 Jun 11;33(6):1078-1093.e12. doi: 10.1016/j.ccell.2018.05.008. Erratum in: Cancer Cell. 2019 Jun 10;35(6):950-952.

14.

BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signaling.

van de Ven M, Liu X, van der Burg E, Klarenbeek S, Alexi X, Zwart W, Dijcks F, Bouwman P, Jonkers J.

J Pathol. 2018 Sep;246(1):41-53. doi: 10.1002/path.5105. Epub 2018 Jul 4.

PMID:
29877575
15.

The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells.

Barazas M, Annunziato S, Pettitt SJ, de Krijger I, Ghezraoui H, Roobol SJ, Lutz C, Frankum J, Song FF, Brough R, Evers B, Gogola E, Bhin J, van de Ven M, van Gent DC, Jacobs JJL, Chapman R, Lord CJ, Jonkers J, Rottenberg S.

Cell Rep. 2018 May 15;23(7):2107-2118. doi: 10.1016/j.celrep.2018.04.046.

16.

Precision cancer therapy: profiting from tumor specific defects in the DNA damage tolerance system.

Buoninfante OA, Pilzecker B, Aslam MA, Zavrakidis I, van der Wiel R, van de Ven M, van den Berk PCM, Jacobs H.

Oncotarget. 2018 Apr 10;9(27):18832-18843. doi: 10.18632/oncotarget.24777. eCollection 2018 Apr 10.

17.

E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer.

Bajrami I, Marlow R, van de Ven M, Brough R, Pemberton HN, Frankum J, Song F, Rafiq R, Konde A, Krastev DB, Menon M, Campbell J, Gulati A, Kumar R, Pettitt SJ, Gurden MD, Cardenosa ML, Chong I, Gazinska P, Wallberg F, Sawyer EJ, Martin LA, Dowsett M, Linardopoulos S, Natrajan R, Ryan CJ, Derksen PWB, Jonkers J, Tutt ANJ, Ashworth A, Lord CJ.

Cancer Discov. 2018 Apr;8(4):498-515. doi: 10.1158/2159-8290.CD-17-0603.

18.

BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance.

Duarte AA, Gogola E, Sachs N, Barazas M, Annunziato S, R de Ruiter J, Velds A, Blatter S, Houthuijzen JM, van de Ven M, Clevers H, Borst P, Jonkers J, Rottenberg S.

Nat Methods. 2018 Feb;15(2):134-140. doi: 10.1038/nmeth.4535. Epub 2017 Dec 11.

PMID:
29256493
19.

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.

Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, Balgobind AV, Wind K, Gracanin A, Begthel H, Korving J, van Boxtel R, Duarte AA, Lelieveld D, van Hoeck A, Ernst RF, Blokzijl F, Nijman IJ, Hoogstraat M, van de Ven M, Egan DA, Zinzalla V, Moll J, Boj SF, Voest EE, Wessels L, van Diest PJ, Rottenberg S, Vries RGJ, Cuppen E, Clevers H.

Cell. 2018 Jan 11;172(1-2):373-386.e10. doi: 10.1016/j.cell.2017.11.010. Epub 2017 Dec 7.

20.

EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation.

Rondinelli B, Gogola E, Yücel H, Duarte AA, van de Ven M, van der Sluijs R, Konstantinopoulos PA, Jonkers J, Ceccaldi R, Rottenberg S, D'Andrea AD.

Nat Cell Biol. 2017 Nov;19(11):1371-1378. doi: 10.1038/ncb3626. Epub 2017 Oct 16.

PMID:
29035360
21.

The role of segmental and durational cues in the processing of reduced words.

van de Ven M, Ernestus M.

Lang Speech. 2018 Sep;61(3):358-383. doi: 10.1177/0023830917727774. Epub 2017 Sep 4.

22.

The role of trait mindfulness in quality of life and asthma control among adolescents with asthma.

Cillessen L, van de Ven MO, Karremans JC.

J Psychosom Res. 2017 Aug;99:143-148. doi: 10.1016/j.jpsychores.2017.06.014. Epub 2017 Jun 15.

PMID:
28712420
23.

A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma.

Wang L, Šuštić T, Leite de Oliveira R, Lieftink C, Halonen P, van de Ven M, Beijersbergen RL, van den Heuvel MM, Bernards R, van der Heijden MS.

Eur Urol. 2017 Jun;71(6):858-862. doi: 10.1016/j.eururo.2017.01.021. Epub 2017 Jan 17.

PMID:
28108151
24.

[Joining forces for quality improvement in tuberculosis control].

Gil L, van de Ven MJ, Richter C.

Ned Tijdschr Geneeskd. 2017;161:D868. Dutch.

PMID:
28098042
25.

Prophylactic window therapy with the clinical poly(ADP-ribose) polymerase inhibitor olaparib delays BRCA1-deficient mammary tumour formation in mice.

van de Ven M, van der Burg E, van der Gulden H, Klarenbeek S, Bouwman P, Jonkers J.

J Pathol. 2017 Mar;241(4):511-521. doi: 10.1002/path.4857. Epub 2017 Jan 23.

PMID:
27943283
26.

[Acute respiratory failure caused by minocycline].

Kok B, van de Ven MJ, van Leeuwen HJ.

Ned Tijdschr Geneeskd. 2016;160:D635. Dutch.

PMID:
27879182
27.

BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.

Drost R, Dhillon KK, van der Gulden H, van der Heijden I, Brandsma I, Cruz C, Chondronasiou D, Castroviejo-Bermejo M, Boon U, Schut E, van der Burg E, Wientjens E, Pieterse M, Klijn C, Klarenbeek S, Loayza-Puch F, Elkon R, van Deemter L, Rottenberg S, van de Ven M, Dekkers DH, Demmers JA, van Gent DC, Agami R, Balmaña J, Serra V, Taniguchi T, Bouwman P, Jonkers J.

J Clin Invest. 2016 Aug 1;126(8):2903-18. doi: 10.1172/JCI70196. Epub 2016 Jul 25.

28.

Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland.

Annunziato S, Kas SM, Nethe M, Yücel H, Del Bravo J, Pritchard C, Bin Ali R, van Gerwen B, Siteur B, Drenth AP, Schut E, van de Ven M, Boelens MC, Klarenbeek S, Huijbers IJ, van Miltenburg MH, Jonkers J.

Genes Dev. 2016 Jun 15;30(12):1470-80. doi: 10.1101/gad.279190.116.

29.

Factors Promoting Mental Health of Adolescents Who Have a Parent with Mental Illness: A Longitudinal Study.

Van Loon LM, Van De Ven MO, Van Doesum KT, Hosman CM, Witteman CL.

Child Youth Care Forum. 2015;44(6):777-799. Epub 2015 Feb 7.

30.

Non-suicidal self-injury among Dutch and Belgian adolescents: Personality, stress and coping.

Kiekens G, Bruffaerts R, Nock MK, Van de Ven M, Witteman C, Mortier P, Demyttenaere K, Claes L.

Eur Psychiatry. 2015 Sep;30(6):743-9. doi: 10.1016/j.eurpsy.2015.06.007. Epub 2015 Aug 7.

PMID:
26260264
31.

Parentification, Stress, and Problem Behavior of Adolescents who have a Parent with Mental Health Problems.

Van Loon LM, Van de Ven MO, Van Doesum KT, Hosman CM, Witteman CL.

Fam Process. 2017 Mar;56(1):141-153. doi: 10.1111/famp.12165. Epub 2015 Jul 24.

PMID:
26208046
32.

Longitudinal associations between asthma control, medication adherence, and quality of life among adolescents: results from a cross-lagged analysis.

Tiggelman D, van de Ven MO, van Schayck OC, Engels RC.

Qual Life Res. 2015 Sep;24(9):2067-74. doi: 10.1007/s11136-015-0945-3. Epub 2015 Feb 26.

PMID:
25715944
33.

Maternal and paternal beliefs, support and parenting as determinants of sport participation of adolescents with asthma.

Tiggelman D, van de Ven MO, van Schayck OC, Engels RC, van Sluijs EM.

J Asthma. 2015 Jun;52(5):492-7. doi: 10.3109/02770903.2014.984844. Epub 2014 Nov 17.

34.

The Common Sense Model in early adolescents with asthma: longitudinal relations between illness perceptions, asthma control and emotional problems mediated by coping.

Tiggelman D, van de Ven MO, van Schayck OC, Kleinjan M, Engels RC.

J Psychosom Res. 2014 Oct;77(4):309-15. doi: 10.1016/j.jpsychores.2014.07.010. Epub 2014 Jul 17.

PMID:
25280828
35.

Moderating effect of gender on the prospective relation of physical activity with psychosocial outcomes and asthma control in adolescents: a longitudinal study.

Tiggelman D, van de Ven MO, van Schayck OC, Engels RC.

J Asthma. 2014 Dec;51(10):1049-54. doi: 10.3109/02770903.2014.941475. Epub 2014 Jul 17.

PMID:
25014780
36.

Type D personality is associated with health behaviors and perceived social support in individuals with coronary heart disease.

Ginting H, van de Ven M, Becker ES, Näring G.

J Health Psychol. 2016 May;21(5):727-37. doi: 10.1177/1359105314536750. Epub 2014 Jun 16.

PMID:
24934433
37.

Sport club participation of adolescents with asthma: maternal factors and adolescent cognitions.

Tiggelman D, van de Ven MO, van Schayck OC, Kleinjan M, Engels RC.

Pediatr Pulmonol. 2014 Sep;49(9):835-41. doi: 10.1002/ppul.22902. Epub 2013 Oct 24.

PMID:
24574428
38.

Effect of Type D personality on medication adherence in early adolescents with asthma.

van de Ven MO, Witteman CL, Tiggelman D.

J Psychosom Res. 2013 Dec;75(6):572-6. doi: 10.1016/j.jpsychores.2013.09.001. Epub 2013 Sep 10.

PMID:
24290048
39.

Effects of asthma on nicotine dependence development and smoking cessation attempts in adolescence.

Van De Ven MO, van Zundert RM, Engels RC.

J Asthma. 2013 Apr;50(3):250-9. doi: 10.3109/02770903.2013.766751. Epub 2013 Feb 25.

PMID:
23347267
40.

Effects of compound heterozygosity at the Xpd locus on cancer and ageing in mouse models.

van de Ven M, Andressoo JO, van der Horst GT, Hoeijmakers JH, Mitchell JR.

DNA Repair (Amst). 2012 Nov 1;11(11):874-83. doi: 10.1016/j.dnarep.2012.08.003. Epub 2012 Oct 7.

PMID:
23046824
41.

Metal exposure and reproductive disorders in indigenous communities living along the Pilcomayo River, Bolivia.

Stassen MJ, Preeker NL, Ragas AM, van de Ven MW, Smolders AJ, Roeleveld N.

Sci Total Environ. 2012 Jun 15;427-428:26-34. doi: 10.1016/j.scitotenv.2012.03.072. Epub 2012 May 9.

PMID:
22575376
42.

Manual vs. automated analysis of polysomnographic recordings in patients with chronic obstructive pulmonary disease.

Stege G, Vos PJ, Dekhuijzen PN, Hilkens PH, van de Ven MJ, Heijdra YF, van den Elshout FJ.

Sleep Breath. 2013 May;17(2):533-9. doi: 10.1007/s11325-012-0714-2. Epub 2012 May 10.

PMID:
22573057
43.

Simultaneous measurement of rotational and translational diffusion of anisotropic colloids with a new integrated setup for fluorescence recovery after photobleaching.

Kuipers BW, van de Ven MC, Baars RJ, Philipse AP.

J Phys Condens Matter. 2012 Jun 20;24(24):245101. doi: 10.1088/0953-8984/24/24/245101. Epub 2012 May 8.

PMID:
22569199
44.

Glucose supplementation does not interfere with fasting-induced protection against renal ischemia/reperfusion injury in mice.

Verweij M, van de Ven M, Mitchell JR, van den Engel S, Hoeijmakers JH, Ijzermans JN, de Bruin RW.

Transplantation. 2011 Oct 15;92(7):752-8. doi: 10.1097/TP.0b013e31822c6ed7.

PMID:
21926943
45.

Fancf-deficient mice are prone to develop ovarian tumours.

Bakker ST, van de Vrugt HJ, Visser JA, Delzenne-Goette E, van der Wal A, Berns MA, van de Ven M, Oostra AB, de Vries S, Kramer P, Arwert F, van der Valk M, de Winter JP, te Riele H.

J Pathol. 2012 Jan;226(1):28-39. doi: 10.1002/path.2992. Epub 2011 Nov 14.

PMID:
21915857
46.

Quality of life of adolescents with asthma: the role of personality, coping strategies, and symptom reporting.

Van De Ven MO, Engels RC.

J Psychosom Res. 2011 Sep;71(3):166-73. doi: 10.1016/j.jpsychores.2011.03.002. Epub 2011 Apr 22.

PMID:
21843752
47.

Semantic context effects in the comprehension of reduced pronunciation variants.

van de Ven M, Tucker BV, Ernestus M.

Mem Cognit. 2011 Oct;39(7):1301-16. doi: 10.3758/s13421-011-0103-2.

PMID:
21547604
48.

A role for the DRD4 exon III VNTR in modifying the association between nicotine dependence and neuroticism.

Ellis JA, Olsson CA, Moore E, Greenwood P, Van De Ven MO, Patton GC.

Nicotine Tob Res. 2011 Feb;13(2):64-9. doi: 10.1093/ntr/ntq210. Epub 2010 Dec 2.

PMID:
21127031
49.

Preparation of capsules containing rejuvenators for their use in asphalt concrete.

García A, Schlangen E, van de Ven M, Sierra-Beltrán G.

J Hazard Mater. 2010 Dec 15;184(1-3):603-11. doi: 10.1016/j.jhazmat.2010.08.078. Epub 2010 Aug 26.

PMID:
20855160
50.

Depressive mood and smoking onset: A comparison of adolescents with and without asthma.

Otten R, Van de Ven MO, Engels RC, Van den Eijnden RJ.

Psychol Health. 2009 Mar;24(3):287-300. doi: 10.1080/08870440701710038.

PMID:
20204994

Supplemental Content

Loading ...
Support Center